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Nanosilver in Biomedicine: 
Advantages and Restrictions
Olga V. Morozova and Dmitry V. Klinov
Abstract
Nanosilver (in a range 1–100 nm) binds with thyol-, amino- and carboxy-groups 
of aminoacid residues of proteins and nucleic acids, thus providing inactivation of 
pathogenic multidrug-resistant microorganisms. Besides antibacterial, antiviral, 
antifungal and anti-cancer properties Ag-based nanomaterials possess anti-inflam-
matory, anti-angiogenesis and antiplatelet features. Drug efficacy depends on their 
stability, toxicity and host immune response. Citrate coated Ag nanoparticles (NPs) 
remain stable colloid solutions in deionized water but not in the presence of ions due 
to replacement of Ag+ by electrolyte ions, potential formation of insoluble AgCl, 
subsequent catalyzed oxidative corrosion of Ag and further dissolution of surface 
layer of Ag2O. Protein shells protect core of AgNPs from oxidation, dissolution, 
aggregation and provide specific interactions with ligands. These nanoconjugates 
can be used for immunoassays and diagnostics but the sensitivity threshold does 
not exceed 10 pg Cytotoxicity of AgNPs conjugated with proteins is associated with 
the rate of intracellular Ag+ release, a ‘Trojan horse’ effect, and exceeds one of Ag+ 
because of endocytosis uptake of NPs but not ions. Relatively toxic nanosilver causes 
immunosuppression of the majority of cytokines with a few exceptions (IL-1β, 
G-CSF, MCP-1) whereas AgNO3 additionally activate TNFα and IL8 gene expression.
Keywords: silver ions, nanoclusters, nanoparticles, nanoconjugates with silver core 
and protein shells, stability, cytotoxicity, immunosupression
1. Introduction
Nanosilver is a generic term that refers to nanoscale Ag materials that have at 
least one dimension less than 100 nm, and which are commonly in the form of 
particles called silver nanoparticles (AgNPs). They remain the most used nano-
structures in commercialized products. Approximately 320 tons of AgNPs are 
manufactured each year [1]. There are nearly 500 consumer products that claim to 
contain nanosilver. At present they are included in nanomedical devices, as tools 
for medical imaging and biosensing [2] which are used for diagnostics. AgNPs 
are also employed as antifungal, antibacterial and antiviral drugs [3], for wound 
dressings and long-term burn care products, anti-bacterial cosmetic lotions for 
both treatment and supplementary drug and/or nutrient delivery [2]. Besides 
broad implementation of the nanosilver in health care systems for diagnostic and 
therapy purposes, medical device coating, medical textiles, contraceptive devices, 
Ag-containing nanostructures are currently used in cosmetics, clothing, household 
and food products.
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The antimicrobial mechanisms of AgNPs include adhesion to cell surface alter-
ing the membrane properties, the formation of free radicals damaging the bacterial 
membranes and viral envelopes, interactions with DNA, and enzyme deterioration 
[4]. Besides that oxidative stress induction, heavy metal ion release that occurs 
in aqueous solutions, producing biologically active Ag+ [5] and non-oxidative 
mechanisms were suggested for silver nanostructures [6]. The generation of reactive 
oxygen species (ROS) inhibits the antioxidant defense system and causes mechani-
cal disruptions of the viral envelopes and cellular membranes. Metal ions are slowly 
released from metal oxide and are absorbed through the cell membranes or viral 
envelopes, followed by direct interaction with the functional groups of proteins 
and nucleic acids, such as mercapto (–SH), amino (–NH2), and carboxyl (–COOH) 
groups, damaging enzyme activity, changing their structure, affecting the normal 
physiological processes, and ultimately inhibiting the pathogens of different origin. 
Currently additional mechanisms of Ag+ antimicrobial action are becoming evident. 
Ag+ ions may react with phosphorus and sulfur groups of surface proteins of the 
cellular membranes, bacterial cell wall as well as virions after posttranslation modi-
fication. Ag+ binds to negative parts of the membranes including viral envelopes, 
making a hole. Ag+ ions damage cytochrome of electron transport chain, impass and 
destroy RNA and DNA. Ag+ hinders DNA replication. Ag+ prevents translation of 
protein due to damage of ribosomal 30S subunits. Ag+ ions are sources for the forma-
tion ROS that have harmful effect to both eukaryotic and bacterial cells. However, 
the impact of metal ions on the pH inside membrane coated vesicles is small and has 
weak antimicrobial activity. Therefore, dissolved metal ions are not determined the 
main antimicrobial mechanism of AgNPs. Moreover, heavy metal ions can indirectly 
act as carriers of antimicrobial substances [6]. Thus, disruption of the cellular 
membranes and viral envelopes, interactions with proteins and nucleic asids [6] 
are the majors known processes of silver-induced disinfecting activity. These three 
independent mechanisms take place simultaneously with reversible equilibrium 
between AgNPs with permanent liberation of Ag+ ions and reverse deposition of 
AgNPs from recovered ions and nanoclusters in cells. The numerous mechanisms of 
action against infectious agents would require multiple simultaneous gene mutations 
for resistance to develop; therefore, a resistance to silver-containing compounds and 
nanostructures is hardly possible [6].
Despite the evergrowing presence of Ag-containing products in the market and 
extensive reports on the antimicrobial activity of AgNPs, insufficient data are cur-
rently available about the principal restrictions for the nanosilver to use as diagnos-
tic and therapeutic agents. Inevitably, from the rapid growth in its manufacture and 
utilization follows an increased environmental and human exposure, whereas the 
potential acute and chronic toxicity has yet to be fully addressed.
Current research is to analyze stability, cytotoxicity and immunomodulation 
potential of Ag+ ions and NPs.
2.  Stability of Ag+ ions, citrate coated AgNPs and their nanoconjugates 
with proteins
AgNPs in the presence of ions and especially after addition of EDTA are 
not stable due to oxidation, dissolution and aggregation during a few hours. 
UV–visible spectroscopy, dynamic light scattering (DLS) and scanning electron 
microscopy (SEM) revealed that the citrate coated AgNPs remained stable col-
loid solutions in deionized water at room temperature for decades but not in the 
presence of ions. Citrate coated AgNPs with the surface Ag2O layer are not stable 
in the presence of phosphate buffer solution (PBS) (0.01 M Na2HPO4/KH2PO4, 
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0.15 M NaCl/KCl) during 1 hour at room temperature (Figure 1) due to replace-
ment of Ag+ by electrolyte ions, potential formation of insoluble AgCl, subsequent 
catalyzed oxidative corrosion of Ag and further dissolution of surface layer of 
Ag2O [7, 8]. To prevent AgNPs dissolution and aggregation various surfactants and 
polymers are introduced during or after synthesis [7]. Coating layers may enhance 
electrostatic and steric repulsion. Adsorption of polymers or nonionic surfactants 
provides steric hindrances depending upon the thickness of the adsorbed layer 
[7]. Nanosilver like other NPs immediately after administration into organism 
becomes wrapped by serum and cellular proteins constituting the protein corona. 
This protein shells decrease the efficiency of targeting by directing the NPs to 
the reticuloendothelial system, by masking the active targeting moieties and 
decreasing their ability to bind to their target receptor, but may re-direct NPs 
towards endogenous targets. The NPs stability depends on the affinity of coating 
molecules to the particle surface, repulsion from neighboring molecules, loss of 
chain entropy upon adsorption, and also nonspecific dipole interactions between 
the macromolecule, the solvent, and the surface. Protein corona protect AgNPs 
from dissolution and aggregation (Figure 1). The nanoconjugates of the noble 
metal NPs with proteins remain stable at +4 °C for several months [8]. Surface 
of nanosilver dynamically adsorbs proteins forming a robust rapidly exchanging 
“biocorona”. A hard corona with long-term stability can be formed with immu-
noglobulins IgG/IgM and fibrinogens and may alter NPs size, shape, surface 
charge and agglomeration state, as well as cellular toxicity and internalization, 
trafficking, opsonization and eventually pattern of biodistribution [8]. Colloids 
of Ag possess high affinity for binding with serum albumins, their ability to bind 
with Staphylococcus aureus protein A is less efficient, whereas a number of proteins 
(for example, human immunodeficiency virus (HIV-1) envelope antigen) cannot 
attach to AgNPs at all. Despite known chemical affinity of sulfur atoms to precious 
metals direct correlation between cystine disulfide bridge content and binding 
with AgNPs was not observed perhaps because of strong bonds between two 
cysteines that stabilize protein conformation.
AgNO3 and its water solutions should be stored in the dark because of possible 
recovery of silver atoms with formation of nanostructures. Thus, fluorescent metal 
nanoclusters with sizes less than 2 nm consisting of a few silver atoms can be recov-
ered from Ag+ in the presence of proteins (albumins, immunoglobulins of different 
classes and origin and NaBH4 (unpublished data).
Figure 1. 
Stability of citrate-coated and protein-coated AgNPs in deionized water and phosphate buffer solution (PBS) 
(0.01 M Na2HPO3/K2HPO4, 0.15 M NaCl/KCl).
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3. Nanosilver in immunodiagnostics
Physicochemical features of the nanosilver determine possible implementation 
in diagnostics. Typical size range of AgNPs 30–80 nm provides high surface to 
volume ratio. Binding of AgNPs with NH2- and SH-groups of proteins is weaker 
compared to AuNPs but protein corona can be formed with the majority of proteins 
including the main blood proteins. However, leaking Ag+ cations may damage 
proteins of envelopes. Extinction, light scattering, surface plasmon resonance 
(SPR) and SERS of AgNPs exceed those of AuNPs in 10 and 100 times, respectively. 
Relatively low price is also an advantage of the nanosilver.
The stable nanoconjugates of AgNPs with immunoglobulins of different ori-
gin, classes and specificity including both polyclonal and monoclonal antibodies 
were constructed by: (1) direct binding of AgNPs with purified IgG or IgM [8]; 
(2) nanoprecipitation of proteins from their solutions in fluoroalcohols [9]; (3) 
physisorption of proteins on the AgNPs surface treated with poly(allylamine)s; (4) 
encapsulation of AgNPs into SiO2 envelope and functionalization with organosi-
lanes. Adsorption of proteins on surfaces of AgNPs is reversible and up to 70% of 
the attached proteins can be eluted. AgNPs possess high affinity for binding with 
immunoglobulins but not with any protein. SiO2 layer on surfaces of metal NPs is 
suitable for silanization and covalent attachment of any protein. Protein corona pre-
vents AgNPs from oxidation, dissolution and aggregation. The developed methods 
of fabrication of AgNPs with protein shells permit to attach any protein at differ-
ent distances from metal core to avoid possible inactivation of proteins, to reduce 
fluorescence fading and to stabilize the nanoconjugates [8].
To detect binding of immobilized antigens in chip with nanosilver conjugated 
with IgG the analyzer based on light scattering of dark field laser of total internal 
reflection with the wave length 532 nm and corresponding software were used. The 
sensitivity limit of the nanosilver-based immunodiagnostic systems was nearly 
10 pg/dot for direct binding of AgNPs with immobilized IgG and 100 pg for 3-layer 
sandwich immunoassay. For comparison, thresholds of commercially available con-
ventional ELISA and xMAP multiplex immunofluorescent analysis with fluorescent 
magnetic microspheres were 1 pg/ml. Specificity of Ag nanoconjugates is limited due 
to their binding with the major blood serum proteins: IgM, IgG, fibrinogen and albu-
mins with increased background level. Protein dots on NH2- and COOH-modified 
surfaces of chips are not homogenous causing problems of dot-to-dot reproducibility.
Taken together, immunodiagnostics based on AgNPs covered with IgG shells 
yields to specificity and sensitivity of the widely used ELISA and xMAP in 10–100 
times. Specificity of immunodetection and ratio of signal to background are limited 
because of binding between AgNPs and blood proteins. Besides the nanoconjugates of 
AgNPs with protein shells, fluorescent silver nanoclusters containing a few recovered 
Ag atoms with sizes less than 2 nm can be used in immunofluorescent diagnostics.
4.  Cytotoxicity of Ag ions and nanoconjugates of AgNPs with major 
blood proteins
The common mass-only dose metric model employed in toxicology for traditional 
substances is not convenient for engineered nanomaterials. Alternative dose metrics 
include particle number, ion release (kinetics, equilibrium), and the total particle 
surface area. Nevertheless, polydisperse particle suspensions, the ambiguity in the 
surface area and concentrations will obscure the analysis. Therefore, Organisation 
for Economic Cooperation and Development recommended that particle number, 
surface area, and mass should all be measured when possible to enable calculation 
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of alternative dose metrics. For AgNPs, both surface area and ion release have been 
reported as effective alternative dose metrics for nanotoxicological assessment.
Silver in ionic, nanoparticulate, and bulk forms behave very differently. Due to 
large surface area AgNPs are able for rapid oxidation, dissolution, reactive capac-
ity and binding with biomolecules [10]. When the size of metallic silver is shrunk 
to nanometre scale, it can enter the cells and cause adverse health effects [10]. 
AgNPs enter into eukaryotic cells either by endosomal uptake or by diffusion. 
They can penetrate in living organisms via several routes including inhalation, oral 
ingestion, intravenous injection, and dermal contact. The American Conference 
of Governmental Industrial Hygienists has established threshold limit values for 
metallic silver (0.1 mg/m3) and soluble compounds of silver (0.01 mg/m3). Long 
exposure of humans to the nanosilver from cations to NPs through oral and inhala-
tion routes can lead to argyria, or skin discoloration, and argyrosis, or discoloration 
of the eyes, as soluble silver incorporates into the tissues with permanent damage 
of skin microvessels and eyes [11]. Studies in vivo with experimental animals have 
revealed AgNPs accumulation in their liver, spleen, and lung. Similarly, AgNPs-
mediated cytotoxicity in mammalian cells depends greatly on the nanoparticle size, 
shape, surface charge, dosage, oxidation state, and agglomeration condition as well 
as the cell type. Smaller AgNPs cause more toxicity than larger ones owing to their 
larger surface area and reactivity [11]. However, currently available data about 
toxicity of silver nanowires (AgNW) (micron-range long with diameters <100 nm) 
remain contradictory [11]. For both short (1.5 mm) and long (10 mm) AgNW after 
inhalation lung inflammation at day 1, disappearing by day 21 has been described, 
and in bronchoalveolar lavage fluid, long AgNW cause neutrophilic and macrophagic 
inflammation [12].
Exposure to different forms of the silver leads to distinct outcomes. Whereas 
elemental silver exposure is not associated with health effects, soluble silver is 
associated with lowered blood pressure, diarrhoea, respiratory irritation, and 
fatty degeneration in the liver and kidneys. Furthermore, after different routes of 
administration including intravenous, intraperitoneal, and intratracheal ways the 
AgNPs can cross the brain blood barrier in vivo and tend to accumulate in liver, 
spleen, kidney and brain [9].
Respiratory tract, gastrointestinal tract, skin, and female genital tract are the 
main entry portals of nanosilver into the human body through direct substance 
exchange with the environment. Additionally, systemic administration is also a 
potential route of entry, since colloidal silver nanoparticles have been exploited for 
diagnostic imaging or therapeutic purposes. Inhalation and instillation experiments 
in rats showed that low concentration, but detectable, ultrafine silver (14.6 ± 1.0 nm) 
appeared in the lung and was subsequently distributed to the blood and other organs, 
such as heart, liver, kidney, and even brain. Nanosilver accumulates in blood, liver, 
lungs, kidneys, stomach, testes, and brain. AgNPs less than 12 nm affect early devel-
opment of fish embryos, cause chromosomal aberrations and DNA damage.
Animal and human studies indicate that it is difficult to remove silver completely 
once it has been deposited in the body; however, nanosilver can be excreted through 
the hair, urine, and feces.
Human liver cells may develop a metabolic-based protection mechanism against 
AgNPs and Ag+. The nanosilver penetration through the blood–brain barrier is still 
debatable. However, even in the absence of Ag in cerebrospinal fluid, Ag-mediated 
neurotoxic complications such as hypoactivity or reverse increased vivacity, 
changes in noradrenaline, dopamine and 5-HT concentrations in the brain were 
observed. Upon oral exposure to AgNO3, the main target organs include liver and 
spleen, followed by testes, kidney, brain and lungs, and AgNPs are formed in vivo 
from Ag+ ions and they are probably composed of silver salts. The elimination of 
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silver from brain and testes is extremely slow [12]. AgNPs may translocate into 
the central nervous system through damaged blood–brain barrier, nerve afferent 
signaling and eye-to-brain ways, and even through olfactory receptors of the brain 
neurons. NPs could stimulate the activation of glial cells to release proinflammatory 
cytokines and generate reactive oxygen species and nitric oxide production, result-
ing in the neuroinflammation, including several immune response relevant signal-
ing pathways [13]. While Ag2S deposits have been seen in the region of cutaneous 
nerves, there is no indication of toxic risk of silver to the peripheral nervous system 
[12]. In vitro data indicate that silver ions alter mitochondrial function, resulting 
in the release of apoptogenic signals and subsequent cell death. Moreover, other 
studies show dose-dependent effects of silver ion on cell replication and other 
developmental endpoints in mammalian cells [12].
Evergrowing production of AgNPs increases their release into aquatic environ-
ments. Once AgNPs get to freshwater, sea or underground water, they oxidize into 
Ag+ ions that are toxic to aquatic organisms. Later on, silver cations can bind with 
abundant anions available in environment with formation of sparingly soluble salts 
AgCl or Ag2S. Marine inhabitants (shrimps, prawns, crabs, lobsters and crayfish), 
are known to be much more vulnerable to the impacts of silver than bacteria [12]. 
By accumulating in aquatic organisms, AgNPs can enter the human body.
AgNPs have been reported to be toxic to human cell lines [11]. Cellular uptake of 
AgNPs takes place either via diffusion (translocation), endocytosis or phagocytosis. 
Upon entering the cytoplasm, AgNPs themselves or Ag+ ions can generate ROS, 
leading to DNA damage, protein denaturation, and apoptosis. AgNPs of differ-
ent sizes and shapes tend to accumulate in the mitochondria, thereby inducing 
mitochondrial dysfunction, i.e., a reduction in mitochondrial membrane potential 
(MMP), and promoting ROS creation [11]. AgNPs cytotoxicity in mammalian cells 
depends on the NPs sizes, shape, surface charge, dosage, oxidation state, agglom-
eration condition and cell type. They induce a dose-, size- and time-dependent 
cytotoxicity, particularly for NPs with sizes less 10 nm.
Surface charge of AgNPs stabilized with citrate anions or protein envelopes 
is a parameter responsible for cellular uptake. In particular, high-level toxicity of 
positively-charged nanoconjugates versus negatively-charged coatings has been 
reported. It can be caused by the adhesion of AgNPs onto the negatively charged cell 
membranes, their consequent entry to the cell, potential release of Ag+ inside the 
cell, damage of cellular proteins and nucleic acids and other cytotoxic effects. For 
instance, the following coatings posses surface charges: (1) positive: polyethyleni-
mine, chitosan, poly-L-lysine and cetyltrimethylammonium bromide; (2) negative: 
bovine serum albumin (BSA), citrate, odium bis(2-ethylhexyl)-sulfosuccinate; (3) 
neutral: polyvinylpyrrolidone.
Ag+ ions alter mitochondrial function, resulting in the release of apoptogenic 
signals and subsequent cell death. They may destroy DNA-dependent DNA replica-
tion, RNA transcription and translation.
Various cellular defense mechanisms, innate immunity of vertebrates and 
accumulation in certain organs for metabolic-based degradation and subsequent 
elimination of the nanosilver provide relative protection.
Endocytosis and exocytosis of AgNPs occur simultaneously and depend on 
physicochemical properties of NPs and protein corona [14]. All nanostructures 
preferentially accumulate in tumor cells due to the enhanced permeability and 
retention (EPR) effect. The tumors possess a leaky vasculature and lack lymphatic 
drainage allowing the drug-loaded NPs to reside at the tumor site for a longer dura-
tion compared to the free drug molecules [14].
The formation of protein corona on NPs’ surfaces upon the in vivo admin-
istration is inevitable. Protein shells of all nanostructures after their systemic 
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administration may explain the lack of the in vitro-in vivo correlation and the 
preclinical to clinical extrapolation. Protein shells provide stability of the nanocon-
gugates, decrease their cytotoxicity and determine the interaction of NPs with the 
target and non-target cells. The chemical composition of protein corona may serve 
as a fingerprint for NPs of certain type since different NPs tend to recruit cellular 
and serum proteins to variable extents. Vitronectin mediates accumulation in integ-
rin receptor-expressing melanoma cells both in vitro and in vivo, while complement 
3 protein (C3) and, as an opsonin and dysopsonin, regulate the balance between the 
the reticuloendothelial system uptake and blood circulation [14].
The cytotoxic effect and oxidative stress of silver ions (Ag+) on mouse lung 
macrophages cells resulted in necrotic rather than apoptotic cell death by reducing 
functional sulfhydryl groups in the cells [12].
Other defense mechanism performed by the most abundant leukocytes - polymor-
phonuclear neutrophils (PMN) is based on neutrophil extracellular traps (NETs) [15]. 
NETs are extracellular fibers consisting of DNA with histones (H3), myeloperoxidase 
and neutrophil elastase. NETs form a barrier that hinders the transmission of patho-
gens and due to high local concentrations of antimicrobial proteins degrade virulence 
factors and kill bacteria. However, high concentrations of active proteins may cause 
host immune damage, contribute to platelet aggregation and cause thrombosis [15, 16]. 
The nanosilver activates polymorphonuclear neutrophils to release NETs did not alter 
the extracellular lactate dehydrogenase level [16].
Noteworthy, that the nanosilver toxicity exceeds one of Ag+. For instance, 
cytotoxic concentration of AgNO3 for 50% of human larynx carcinoma HEp-2 cells 
(CC50) was 50 μg/ml, whereas for the nanoconjugates of AgNPs with surface pro-
teins CC50 = 0.1 o.u. = 1.4 μg/ml (calculations are based on the calibration curve of 
atomic absorption spectroscopy (AAS) data). One of possible explanations is AgNPs 
limited cellular uptake. At present there is not evidence of the efficient uptake or 
intracellular localization of the citrate coated AgNPs conjugated with fluorescent 
proteins. Intracellular Ag+ release appears to be responsible for the toxicity since the 
cultural media after treatment of cells with the nanosilver do not cause any cytotox-
icity. Thus, AgNPs were toxic for mammalian cells and the cytotoxicity is associated 
with the rate of intracellular Ag release, a ‘Trojan horse’ effect [1, 9].
5. Inhibition of innate immunity with the nanosilver
Cytotoxicity of the nanosilver evidently determines host defence such as apop-
tosis, necrosis [2] and NETs formation [16]. Moreover, AgNPs, but not Ag+ ions, 
decrease the viability and the cytotoxic potential of natural killer (NK) cells secret-
ing cytokines and killing damaged cells [12].
Nanosilver possess anti-inflammatory properties in both animal models and in 
clinic. Thus, AgNPs inhibit the expression of proinflammatory cytokines trans-
forming growth factor (TGF) -β and tumor necrosis factor(TNF) -α. Nanosilver 
administration attenuates nasal symptoms of allergic rhinitis in mice and inhibites 
immunoglobulin IgE, IL-4, IL-10. In clinical study, wound dressing containing 
AgNPs promoted the healing of chronic leg ulcers due to antibacterial effect in the 
wound and by decreasing inflammatory response. Ability of nanosilver to reduce 
cytokine release and production of matrix metalloproteinases, decrease lymphocyte 
and mast cell infiltration, and induce apoptosis in inflammatory cells may explain 
their anti-inflammatory mechanisms [17].
Innate immunity induction with AgNO3 and AgNPs conjugated with the major 
blood proteins – albumin, fibrinogen, immunoglobulines was assayed by xMAP 






















Th1 Th2 Th17 Others
IFNγ TNFα IL-1β IL-12(p70) IL-2 IL-4 IL-5 IL-6 IL-7 IL-8 IL-10 IL-13 IL-17A G-CSF GM-CSF MCP-1 
(MCAP)
MIP-1β
AgNO3 1.03 1.15 ↑ 1.38 ↑ 0.70 0.74 0.84 0.88 0.85 0.70 3.71 ↑ 0.78 0.81 0.97 1.12 ↑ 0.92 1.19 ↑ 1.17 ↑
AgNP-BSA 0.76 0.72 0.70 0.70 0.82 0.74 0.70 0.75 0.50 0.64 0.78 0.69 0.76 0.78 0.79 0.85 0.76
AgNP-Fb 0.72 0.65 1.00 0.72 0.78 0.75 0.82 0.75 0.55 1.00 0.77 0.83 0.84 1.00 0.83 1.15 ↑ 0.97
AgNP-hIgG 0.68 0.51 2.11 ↑ 0.54 0.48 0.43 0.60 0.41 0.44 0.34 0.54 0.50 0.97 1.20 ↑ 0.83 0.76 0.66
Table 1. 
Multiplex immunofluorescent xMAP data for 17 inflammation biomarkers in HEp-2 cells in 2 days posttreatment with 5 μg/ml AgNO3 and 0.02 o.u. of nanoconjugates of AgNP-with BSA, 
fibrinogen (Fb) or hIgG. Normalization was carried out as a ratio of mean fluorescence intensity (MFI) of fluorescent magnetic beads after treatment with Ag ions or nanoconjugates to MFI of 
control intact HEp-2 cells.
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The maximal production of all 17 studied biomarkers including T-helper (Th)1 
cytokines: interferon (IFN) γ, tumour necrosis factor (TNF) α, interleukin (IL-
1β), IL-12 (p70); Th2 cytokines: IL-2, 4, 5, 6, 7, 8, 10, 13; Th17 – IL-17A and other 
inflammation biomarkers: granulocyte colony-stimulating factor (G-CSF), granu-
locyte macrophage colony stimulating factor (GM-CSF), Monocyte Chemotactic 
Protein 1 (Monocyte Chemotactic And Activating Factor) (MCP-1 (MCAF)), 
Macrophage Inflammatory Protein 1β (MIP-1β) was registered during first two 
days posttreatment. In HEp-2 human cell line in 2 days posttreatment with 5 μg/
ml AgNO3 (for comparison, cytotoxic concentration for 50% cells (CC50) of 
AgNO3 for HEp-2 cells is 50 μg/ml) the significant up regulation was registrated 
for IL-1β (slight increase in 1.38 times up to 0.08 pg/ml), IL-8 (significant growth 
in 3.7-times up to 0.94 pg/ml) whereas steady production of TNF α (growth in 1.15 
times), G-CSF (up in 1.12) MCP-1 (MCAP) (increase in 1.17 times up to 0.39 pg/
ml) was observed; down regulation – for regulatory IL-10 (below the IL-10 produc-
tion in control intact cells with less than 0.05 pg/ml and therefore undetectable in 
ELISA with detection limit 1 pg/ml) (Table 1). IL production is known to depend 
on the origin of human cells. Thus, IL-1β is mainly produced by macrophages and 
monocytes but HEp-2 cell line is derived from larynx carcinoma cells and HT-29 – 
from human colorectal adenocarcinoma cells. IL-1β is responsible for initiation and 
regulation of inflammation, stimulation of acute phase cytokines such as IL-2, −3, 
−6, TNF-α as well as for temperature growth and fever. Therefore, inflammation is 
hardly possible with low level of IL-1β and stimulated cytokines. The only excep-
tion was IL-1β-induced up-regulation of IL-8 (Table 1) which is associated with 
acute and chronic inflammation. Silver ions at concentration lower CC50 were not 
toxic for the human cell line and could not penetrate through membranes in cells. 
Therefore, the observed immunomodulation with AgNO3 was so modest (if any).
Immunomodulation with nanoconjugates of AgNPs covered with the major 
blood proteins: albumins, fibrinogen, or immunoglobulins differed (Table 1). 
Significant increase in 2.11-times of IL-1β production (up to 0.12 pg/ml) and G-CSF 
(in 1.20-times) was detected in 2 days after treatment of HEp-2 cells with AgNPs-
hIgG simultaneously and similar to its growth after AgNO3 addition. However, the 
growth did not stimulate production of other cytokines (Table 1). Growth of MCP-1 
(MCAP) secretion (up to 0.37 pg/ml) was caused by AgNPs-fibrinogen. Inhibition 
of IL-8 and regulatory IL-10 production in the presence of all nanoconjugates with 
Ag core and protein shells resulted in slight changes (if any) of 17 biomarkers. 
Noteworthy that AgNPs-BSA caused decreased production of all inflammation 
biomarkers studied (Table 1). However, the lowest concentrations below 50% of the 
corresponding values in control cells were found after treatment with AgNPs-hIgG 
perhaps due to reverse regulation of innate immine response with antibodies.
6. Conclusion
Limited stability of nanosilver without stabilizing envelopes in biologically relevant 
media, cytotoxicity for both eukaryotic and bacterial cells, negligible cellular uptake 
restrict their further implementation for combined antiviral and antibacterial therapy. 
However, spontaneous binding with the major blood proteins and anti-inflammatory 
properties with inhibition of cytokine production at the early stages after treatment 
may be helpful in prevention of cytokine storm caused by RNA-containing viruses.
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